| Avalyn Pharma Inc. | 1.68M | US$55.2M | 10.4% |
| Johnson & Johnson | 139K | US$35.3M | 6.6% |
| Gilead Sciences, Inc. | 269K | US$34M | 6.4% |
| Bridgebio Pharma, Inc. | 455K | US$33.9M | 6.4% |
| Syndax Pharmaceuticals, Inc. | 1.22M | US$26.6M | 5.0% |
| Definium Therapeutics, Inc. | 563K | US$26.5M | 5.0% |
| Bristol-myers Squibb Company | 413K | US$23.8M | 4.5% |
| Parabilis Medicines, Inc. | 824K | US$22.6M | 4.2% |
| Natera, Inc. | 82,181 | US$22.3M | 4.2% |
| Incyte Corporation | 192K | US$21.7M | 4.1% |
| Septerna, Inc. | 536K | US$18M | 3.4% |
| Mineralys Therapeutics, Inc. | 649K | US$17.5M | 3.3% |
| Heartflow, Inc. | 583K | US$17.1M | 3.2% |
| Corvus Pharmaceuticals, Inc. | 1.08M | US$16.1M | 3.0% |
| Protagonist Therapeutics, Inc. | 107K | US$13.1M | 2.5% |
| Disc Medicine, Inc. | 159K | US$11.7M | 2.2% |
| Edwards Lifesciences Corporation | 125K | US$11.3M | 2.1% |
| Axsome Therapeutics, Inc. | 43,182 | US$10.6M | 2.0% |
| Ultragenyx Pharmaceutical Inc. | 316K | US$10.6M | 2.0% |
| Kailera Therapeutics, Inc. | 469K | US$10.3M | 1.9% |
| Karyopharm Therapeutics Inc. | 941K | US$9.19M | 1.7% |
| Odyssey Therapeutics, Inc. | 458K | US$8.57M | 1.6% |
| Kardigan, Inc. | 313K | US$7.45M | 1.4% |
| Eledon Pharmaceuticals, Inc. | 1.7M | US$6.68M | 1.3% |
| 4d Molecular Therapeutics, Inc. | 471K | US$6.27M | 1.2% |
| Veradermics, Incorporated | 45,856 | US$5.64M | 1.1% |
| Dyne Therapeutics, Inc. | 245K | US$5.44M | 1.0% |
| Fractyl Health, Inc. | 6.17M | US$4.9M | 0.92% |
| Dianthus Therapeutics, Inc. | 32,941 | US$3.21M | 0.60% |
| Bridgebio Oncology Therapeutics, Inc. | 318K | US$2.43M | 0.46% |
| Protara Therapeutics, Inc. | 520K | US$1.99M | 0.37% |
| Hyperfine, Inc. | 1.32M | US$1.78M | 0.33% |
| Ataibeckley Inc. | 197K | US$1.04M | 0.19% |
| Metagenomi Therapeutics, Inc. | 529K | US$630K | 0.12% |
| Outset Medical, Inc. | 118K | US$511K | 0.10% |
| Sensei Biotherapeutics, Inc. | 14,718 | US$368K | 0.07% |
| Cytokinetics, Incorporated | 0 | US$0 | 0.00% |
| Kalvista Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Phathom Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Supernus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Tyra Biosciences, Inc. | 0 | US$0 | 0.00% |
| Abivax Sa | 0 | US$0 | 0.00% |
| Adaptive Biotechnologies Corporation | 0 | US$0 | 0.00% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |
| Boston Scientific Corporation | 0 | US$0 | 0.00% |